These include: Nausea and vomiting typically most pronounced during dose escalation and often improving with continued use Diarrhoea or constipation affecting bowel habit regularity Abdominal pain and discomfort ranging from mild cramping to more significant discomfort Dyspepsia and gastro-oesophageal reflux related to delayed gastric emptying Injection site reactions are classified as 'common' (affecting up to 1 in 10 people) and may include redness, itching, bruising, or localised swelling at the subcutaneous injection site
In fact, sometimes in weight loss patients, the scars will actually turn out a little better [than average], says Dr
At 72 weeks, participants receiving 7.2 mg lost an average of 20.7% of their body weight, compared to 17.5% on 2.4 mg
When comparing options, look closely at the level of clinical involvement rather than relying on before-and-after photos or broad claims online
Users who quit before 16 weeks often miss the inflection point where results become obvious